Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bupi Xiaoji oral liquid is a Traditional Chinese Medicine (TCM) formulation developed as a hospital-made preparation (医院制剂) by the First Affiliated Hospital of Air Force Military Medical University (Xijing Hospital). It is primarily indicated for pediatric conditions characterized by spleen deficiency and food accumulation, such as anorexia and digestive stagnation. The formulation is currently being evaluated in clinical research as an adjunctive treatment for pediatric mesenteric lymphadenitis, where it is intended to alleviate abdominal pain and reduce lymph node inflammation. As a TCM product, its therapeutic effects are attributed to a synergistic blend of herbal extracts that tonify the digestive system and resolve stagnation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bupi xiaoji oral liquid.